Why does sotagliflozin (Inpefa) reduce heart attack and stroke risk when similar medications don't?
A new @umichmedicine study published in @jclinicalinvest points to a potential answer: it directly reduces platelet activation and blood clot formation.
michmed.org/72qwr
A new @umichmedicine study published in @jclinicalinvest points to a potential answer: it directly reduces platelet activation and blood clot formation.
michmed.org/72qwr